BELLICUM PHARMACEUTICALS, INC — Form D
BELLICUM PHARMACEUTICALS, INC of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2009-03-31. The offering totals $1.5M, of which $500K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2009-03-31
- Form: D
- Accession: 0001358403-09-000004
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $1.5M
- Amount sold: $500K
- Remaining: $1.0M
- Minimum investment: $11K
- Investors: 11
- Date of first sale: 2009-03-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-87889
Issuer
- Name: BELLICUM PHARMACEUTICALS, INC
- CIK: 0001358403
- Entity type: Corporation
- Jurisdiction: DE
- Incorporated: 2004
- Address: 6400 FANNIN, HOUSTON, TX, 77030
- Phone: 7133416470
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Kevin Slawin | Director | Houston, TX |
| Kevin Slawin | Executive Officer | Houston, TX |
| Thomas J Farrell | Director | San Diego, CA |
| Thomas J Farrell | Executive Officer | San Diego, CA |
| Dennis K Stone | Director | Houston, TX |
| David M Spencer | Executive Officer | Houston, TX |
| Annemarie K Moseley | Executive Officer | Houston, TX |
| Kevin M Slawin | Director | Houston, TX |
| Kevin M Slawin | Executive Officer | Houston, TX |
| James F Brown | Director | Houston, TX |
| Frank M McGuyer | Director | Houston, TX |
| Ken K Moseley | Executive Officer | Houston, TX |
| Joseph K Senesac | Executive Officer | Houston, TX |
| Thomas Farrell | Director | Houston, TX |
| Thomas Farrell | Executive Officer | Houston, TX |
| David Spencer | Executive Officer | Houston, TX |
| Frank McGuyer | Director | Houston, TX |
Other filings by this issuer (5)
More